Healthcare (Prescription Drugs)

This bill amends Wyoming's Pharmacy Act to raise the minimum age for pharmacists to administer vaccines from 3 to 7 years old, directly affecting children under 7 who previously could receive immunizations from pharmacists. It also adds protections preventing employers from discriminating against pharmacists who decline to provide collaborative pharmacy care or administer vaccines to children under 13. The bill requires the Board of Pharmacy to create rules for collaborative care and vaccine administration, with most provisions taking effect July 1, 2026. These changes clarify pharmacist authority, patient eligibility, and workplace protections under the state's pharmacy regulations.

HB 13 would allow human-use ivermectin to be sold as an over-the-counter medication in Wyoming without a prescription or consultation with a healthcare provider. The bill directly affects pharmacies and consumers by removing current prescription requirements for this medication. Key provisions define "over-the-counter medication" and specify that ivermectin cannot be classified as a dangerous substance or a controlled substance under existing laws. The law would take effect on July 1, 2026.

Wyoming's SF 19 allows schools to stock and administer epinephrine using auto-injectors, nasal sprays, or other FDA-approved devices for severe allergic reactions without requiring a student-specific prescription. It directly affects schools, school nurses, and trained staff by enabling them to provide emergency treatment to students experiencing anaphylaxis. The bill requires schools to develop allergy management guidelines, track incidents, and maintain records of trained personnel, while also providing liability protection for good-faith administration (excluding gross negligence). It updates definitions to include all approved epinephrine delivery methods and specifies that administering stock epinephrine does not constitute the practice of medicine.